Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
IMDUR
Generic name / active ingredient
isosorbide mononitrate extended-release tablets
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-31

Copy from the pack in hand

Source-linked reading points

  • Do not self-convert, alternate or substitute IMDUR extended-release tablets, MONOKET immediate-release tablets and sublingual/buccal nitroglycerin from a nitrate family or milligram figures.
  • PDE-5 inhibitors such as sildenafil, tadalafil or vardenafil with an organic nitrate may cause dangerous hypotension. Do not invent a separation interval to bypass the contraindication; promptly review the complete list with the prescriber.
  • Dizziness, hypotension or syncope requires priority review with antihypertensives, diuretics, other vasodilators or alcohol. Unsteadiness on standing or a fall in an older person needs timely assessment.
  • The exact UK 60 mg product is described as divisible but must not be chewed or crushed. This is not universal permission for every IMDUR, generic extended-release or other-market product.

Reviewed presentation examples — compare every field

  • Isosorbide mononitrate 30 mg per tablet; historical RLD currently DISCNNDA 020225 / Product 001
  • Isosorbide mononitrate 60 mg per tablet; historical RLD currently DISCNNDA 020225 / Product 002
  • Isosorbide mononitrate 120 mg per tablet; historical RLD currently DISCNNDA 020225 / Product 003
  • Isosorbide mononitrate 60 mg per tablet; this exact UK product is divisible but must not be chewed or crushedPL 46500/0002

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-31
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image